Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 94 results found. Search for [ HCQ ]

Results 1 to 21 of 94
BusinessToday.In
July 3, 2020
The centre announced a list of all essential medical equipments that has have been domestically manufactured and distributed across the country. It also said that it has distributed more than 6.12 crore HCQ tablets


BusinessToday.In
New Delhi, June 21, 2020
These two companies have been approved at a time when coronavirus cases in India are spiralling like never before and putting tremendous pressure on our healthcare system


PB Jayakumar
June 19, 2020
The move comes after an inter-ministerial High-Level Empowered Committee assessment that the number of manufacturing units of HCQ have increased three times


PTI
June 18, 2020
Close contacts -- unprotected individuals who had been within a metre of a person with COVID-19 less than two days before their symptoms developed -- were traced, quarantined, and tested for SARS-CoV-2 on days 1 and 14


Reuters
June 18, 2020
Data from a UK-led clinical trial known as the Recovery trial found last week that the anti-malaria drug showed no benefit for patients with COVID-19


PB Jayakumar
June 16, 2020
About six Indian companies like Cipla, Jubilant, Hetero, Syngene, Dr Reddy's and Zydus Cadila were licensed to make and distribute the drug in over 120 geographies


PTI
June 16, 2020
On March 28, FDA had issued emergency use authorization (EUA) for use of oral formulations of chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ) to be distributed from the Strategic National Stockpile (SNS)


BusinessToday.In
New Delhi, June 14, 2020
Remdesivir can be administered to patients with moderate disease (those on oxygen), though it should not administered to patients with severe renal impairment, pregnancy or lactating females and children, health ministry guidelines suggest


PTI
June 14, 2020
The tally of confirmed cases also saw the biggest one-day jump of over 14,000 and reached 3.13 lakh, as per the latest numbers announced by states and union territories


BusinessToday.In
New Delhi, June 5, 2020
Coronavirus vaccine update: AstraZeneca and Serum Institute of India have signed a licencing agreement to supply 1 billion doses of the Oxford University vaccine to middle and low-income countries, including India


BusinessToday.In
New Delhi, June 5, 2020
COVID-19 drug: The clinical trial will be conducted across 12 centres in India in 210 patients for 10 days and the results of the clinical trial are expected by October


PTI
June 5, 2020
Modi was among around 35 heads of state and government participants, including US President Donald Trump, to virtually join the conference aimed at raising USD 7.4 million to immunise a further 300 million children in the world's poorest countries by 2025


BusinessToday.In
New Delhi, June 5, 2020
Guidelines for malls and restaurants: Cinema halls, gaming arcades and play area for children will not be opened. Malls and restaurants within containment zones would continue to remain closed


Reuters
June 5, 2020
The observational study published in the Lancet on May 22 said it looked at 96,000 hospitalized COVID-19 patients, some treated with the decades-old malaria drug


Reuters
June 4, 2020
In the first major study comparing hydroxychloroquine to a placebo to gauge its effect against the new coronavirus, University of Minnesota researchers tested 821 people who had recently been exposed to the virus or lived in a high-risk household


BusinessToday.In
New Delhi, June 4, 2020
Coornavirus in India live updates: Maharashtra is the worst-affected with 74,860 cases, Delhi has reported 23,645 cases so far


BusinessToday.In
New Delhi, June 3, 2020
WHO chief Tedros Adhanom Ghebreyesus  said that clinical trials of anti-malaria drug hydroxychloroquine will resume as a potential treatment for coronavirus


PTI
June 3, 2020
Before becoming the MEA spokesperson, Kumar was serving as Consul General of India in Frankfurt


BusinessToday.In
June 3, 2020
The Lancet study indicated that while the hydroxychloroquine drug had no positive effect on COVID-19 patients, administering it to them can increase their risk of death as was identified in the study group


BusinessToday.In
New Delhi, May 29, 2020
Three clinical trials are undergoing to test Nafamostat in Covid-19 patients; these trials are being led by the University of Tokyo Hospital, Japan; Gyeongsang National University Hospital (South Korea); and a collaborative trial by University Hospital, Italy, University of Zurich, Switzerland and Yokohoma City University, Japan


PAGES 1 OF 5  12345